Health ❯ Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Pricing Clinical Trials Drug Safety Weight Loss Weight Loss Drugs Drug Regulation Cancer Treatment Medications

Gilead to Buy Ouro Medicines for Up to $2.18 Billion to Secure BCMA Autoimmune Drug Rights

The deal gives Gilead control of a Keymed‑origin therapy it plans to advance worldwide for autoimmune conditions.

Macau Approves Anktiva for BCG-Unresponsive Bladder Cancer in First Asia Nod

Stories older than 24h

Apogee to Report 52-Week Phase 2 Data for Zumilokibart in Atopic Dermatitis Today

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

Corcept Faces Securities Class Action Over Relacorilant Disclosures as Firms Rally Investors Before April 21 Deadline

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Taysha Advances Rett Gene Therapy Program With Pivotal Dosing, FDA Alignment and Q2 Data Timeline

FDA Clears 7.2‑mg Wegovy as India Enters Generic Semaglutide Era

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Pfizer’s Talzenna Plus Xtandi Delivers Phase 3 Win in Hormone-Sensitive Prostate Cancer

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

For Third Time, FDA Rejects Aldeyra’s Dry-Eye Drug Reproxalap Over Efficacy

Artelo Secures Fully Funded Investigator-Led Glaucoma Trial With Belfast Health Trust

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims

India Braces for 50+ Semaglutide Generics as Patent Expires Friday